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2 
ABSTRACT 1 
Phosphoribosyl amine (PRA) is an intermediate in purine biosynthesis and also required for 2 
thiamine biosynthesis in Salmonella enterica. PRA is normally synthesized by phosphoribosyl 3 
pyrophosphate (PRPP) amidotransferase, a high-turnover enzyme of the purine biosynthetic 4 
pathway encoded by purF. However, PurF-independent PRA synthesis has been observed in 5 
strains with different genetic backgrounds and growing under diverse conditions. Genetic 6 
analysis has shown that the anthranilate synthase-phosphoribosyltransferase (AS-PRT) enzyme 7 
complex, involved in the synthesis of tryptophan, can play a role in the synthesis of 8 
phosphoribosyl amine (PRA). This work describes the in vitro synthesis of PRA in the presence 9 
of the purified components of AS-PRT complex. Results from in vitro assays and in vivo studies 10 
indicate the cellular accumulation of phosphoribosyl anthranilate can result in non-enzymatic 11 
PRA formation sufficient for thiamine synthesis.  These studies have uncovered a mechanism 12 
used by cells to redistribute metabolites to ensure thiamine synthesis, and may define a general 13 
paradigm of metabolic robustness.  14 
 15 
INTRODUCTION 16 
Phosphoribosyl amine (PRA) participates in cellular metabolism as an intermediate required for 17 
both purine and thiamine production (11, 21, 22), and is synthesized by the first enzyme in the 18 
purine biosynthetic pathway (PurF) (19, 21). In Salmonella enterica, the activity of PurF can be 19 
bypassed in thiamine (but not purine) synthesis, indicating the existence of alternative pathways 20 
generating at least small amounts of PRA (10, 24). We have hypothesized that PRA synthesis in 21 
the absence of PurF is the result of promiscuous enzymes involved in different metabolic 22 
processes. This hypothesis was supported by the demonstration that in at least two situations the 23 
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3 
anthranilate synthase- phosphoribosyltransferase (AS-PRT) complex is required for PRA 1 
formation in vivo (4, 27). The AS-PRT complex is a multi-functional enzyme (chorismate 2 
pyruvate-lyase, EC 4.1.3.27 and N-(5’-phosphoribosyl)-anthranilate pyrophosphate 3 
phosphoribosyltransferase, EC 2.4.2.18) that catalyzes the first and second steps of tryptophan 4 
biosynthesis (2, 34) (Fig. 1A). The products of the trpE and trpD genes, the first two in the 5 
tryptophan operon, compose this allosteric heterotetrameric (TrpE2-TrpD2) enzyme, which has 6 
been extensively studied (2, 34). The AS-PRT complex catalyzes both the formation of 7 
anthranilate from chorismate and L-glutamine (2, 14) and the formation of N-(5’-8 
phosphoribosyl)-anthranilate from anthranilate and 5-phosphoribose-1-pyrophosphate (PRPP) 9 
(Fig. 1A) (2, 13). Phosphoribosyl transfer requires the carboxy-terminal domain of the TrpD 10 
subunit (12) and the ability of the TrpD subunit to perform this reaction is equivalent to that of 11 
the complex (TrpE2-TrpD2) (2, 13). Each of the enzymatic activities is negatively feedback-12 
regulated by tryptophan at a well-defined allosteric binding site (20, 34, 35).  13 
 The step in the biosynthetic pathway for tryptophan following the action of AS-PRT is 14 
catalyzed by the product of trpC, N-(5’-phosphoribosyl)anthranilate isomerase, EC 5.3.1.24 (PR-15 
AnI); indole-3-glycerol-phosphate synthase, EC 4.1.1.48 (IGPS). TrpC is a monomeric 16 
bifunctional enzyme (18). The two catalytic activities of this enzyme are located on different 17 
domains of the protein and act sequentially in the biosynthetic pathway (Fig. 1B). While the N-18 
terminal domain contains the IGPS activity, the C-terminal domain catalyzes the isomerization 19 
of PR-anthranilate to 1-(o-carboxyphenylamino)-1-deoxyribulose 5-phosphate (CdRP) (15, 33), 20 
which is the first of the two reactions metabolically. Both domains consist of a parallel β-barrel 21 
core of eight strands that form a pocket where the active site is located, and eight surrounding α-22 
helices (26). 23 
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4 
This study was initiated to better understand the contribution of AS-PRT to PRA 1 
formation relevant in vivo. Characterization of PRA formation in vitro with purified proteins led 2 
to the identification of PRA formation in vivo that was dependent on both the TrpDE complex 3 
and the status of flux through the tryptophan biosynthetic pathway.  Thus, this study describes a 4 
mechanism by which the activity of the AS-PRT enzyme can contribute to PRA production in 5 
the cell in a flux dependent manner.  6 
 7 
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5 
MATERIAL AND METHODS  1 
Culture media and chemicals.  Culture media was obtained from Difco (Franklin Lake, NJ). 2 
Glutamine, glycine, ribose-5-phosphate (R5P), 5-phosphoribose-1-pyrophosphate (PRPP), 3 
ammonium chloride and ammonium sulfate, were obtained from Sigma (St. Louis, MO). Tris 4 
base, methanol and pyridine were from Fisher Scientific (Pittsburgh, PA). ATP was from Fisher 5 
Biotech (Pittsburg, PA). K2HPO4 and KH2PO4 were obtained from Mallinckrodt LabGuard 6 
(Phillipsburg, NJ). [1-14C]- glycine was from New England Nuclear (Boston, MA). Cellulose 7 
PEI plates were from Selecto Scientific (Suwanee, GA). No-carbon E medium of Vogel and 8 
Bonner (8, 31) supplemented with MgSO4 (1 mM) and glucose (11 mM) was used as minimal 9 
medium. When present in the culture medium, the following compounds were used at indicated 10 
concentrations: adenine, 0.4 mM; thiamine, 0.5 µM; and tryptophan, 0.5 mM.  Difco nutrient 11 
broth (8 g/l) with NaCl (5 g/l) or Luria-Bertani broth was used as rich medium.  Difco BiTek 12 
agar was added (15 g/l) for solid medium. Tetracycline was added as needed to 20 µg/ml final 13 
concentration in rich media.  14 
Abbreviations.  Abbreviations used extensively throughout the manuscript are: GAR, 15 
glycinamide ribonucleotide; PRA, phosphoribosyl amine; R5P, ribose-5-phosphate; PR-Ant, 16 
phosphoribosyl anthranilate; TrpD, anthranilate synthase component II; TrpC, N-(5’-17 
phosphoribosyl)anthranilate isomerase, indole-3-glycerol-phosphate synthase; PurD, 18 
glycinamide ribonucleotide synthetase. 19 
Bacterial strains.  All strains used in this study are derivatives of Salmonella enterica serovar 20 
Typhimurium strain LT2 and are listed with their genotypes in Table 1. Tn10d(Tc) refers to the 21 
transposition-defective mini-Tn10 (Tn10∆16∆17) (32).  22 
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6 
Genetic methods. Transduction methods.  Transductional crosses were performed using the 1 
high-frequency general transducing mutant of bacteriophage P22 (HT105/1, int-201) (28) as has 2 
been described previously (9). Transductants were purified by colony isolation on nonselective 3 
green indicator plates (6), and verified to be phage-free by cross-streaking with phage P22. 4 
Strain constructions. Isolation of trp mutants. A P22 lysate grown on wild-type strain DM1 5 
previously treated with diethylsulfate (DES) was used to transduce strain DM6806 (purF2085 6 
gnd-181 trp::Tn10d(Tc)) to Trp+ on minimal medium with adenine and thiamine.  Trp+ 7 
transductants were screened for their ability to grow on minimal adenine medium. All putative 8 
Trp+ Thi+ mutants were reconstructed by transduction into strain DM8916 (purF2085 gnd-181 9 
∆trpEDCBA), prior to further characterization. An isogenic strain, carrying a wild-type trp 10 
operon, was generated by transducing DM8916 to Trp+ with a lysate grown on a wild-type donor 11 
strain (DM1). 12 
Phenotypic analysis. Liquid growth. Strains to be analyzed were grown to full density in 13 
nutrient medium at 37oC. After overnight incubation, cells were pelleted and resuspended in an 14 
equal volume of saline (85 mM). A 50-µl sample of this suspension was used to inoculate 5 ml 15 
of the appropriate medium. Culture tubes were incubated at 37oC with shaking, and growth was 16 
monitored as optical density at 650 nm on a Bausch and Lomb Spectronic 20D. Alternatively, 2 17 
µl of the cell suspension was used to inoculate 200 µl of the appropriate medium contained in 18 
each well of a 96-well micro titer plate.  Growth at 37oC was monitored using a microplate 19 
spectrophotometer Spectra-Max Plus. The specific growth rate was determined as µ = 20 
ln(X/Xo)/T, where X = OD650 during the linear portion of the growth curve and T = time.  21 
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7 
Solid media. Nutritional requirements were measured by growing the strains on rich agar 1 
medium and replica plating to minimal agar medium containing the appropriate nutrients. 2 
Growth was assessed after 24 h incubation at 37oC. Cross-feeding was measured by spotting 3 
relevant samples (cells or supernatants) on a soft agar overlay seeded with a strain containing 4 
trpE8 (old designation trpA8 (3), kindly provided by J. Roth).  5 
Plasmid constructs. Genomic DNA of strain DM6418 (purF2085  gnd-181  zdd-6 
9147::Tn10d(Tc)) was purified from bacterial cells using an Easy-DNA kit (Invitrogen Life 7 
Technologies; Carlsbad, CA). Cloned Pfu DNA polymerase from Pyroccoccus furiosus 8 
(Stratagene; La Jolla, Calif.) was used in PCR reactions. The PCR fragment corresponding to the 9 
trpD (1610 bp) gene was gel-purified, digested with the appropriate restriction enzymes and 10 
cloned into the expression vector pET-28a (Novagen, Darmstadt, Germany). The ligation mix 11 
was transformed into Escherichia coli strain DH5α, and DNA sequencing (University of 12 
Wisconsin Biotechnology Center-Nucleic Acid and Protein Facility) was used to verify the 13 
plasmid constructs.  14 
Purification of TrpD enzyme. An expression vector containing the trpD gene under control of T7 15 
promoter (pET-trpD) was freshly transformed into Escherichia coli BL21. Overnight cultures 16 
were used to inoculate Luria-Bertani (LB) broth supplemented with 50 µg/ml kanamycin and the 17 
cultures were grown to an optical density at 650nm of 0.6 at 37°C. The cells were cooled to 30°C 18 
and then induced with 1.0 mM isopropyl-β-D-thiogalactopyranoside (IPTG). The cells were 19 
grown for an additional 5 h at 30°C, harvested and resuspended in Binding buffer (5 mM 20 
imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9). All subsequent purification steps were 21 
performed at 4°C. Cells were disrupted using a French pressure cell at 104 kPa, followed by brief 22 
sonication using a Sonic Dismembrator 550 (Fisher Scientific). Clarified cell-free extract was 23 
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8 
obtained by centrifugation at 23,700 x g for 45 min at 4oC. The supernatant was filtered and 1 
loaded onto a 10-ml Ni-HisBind resin column equilibrated with Binding buffer. Unbound 2 
proteins were washed from the resin with 20 mM Tris-HCl pH 7.9, 6 mM imidazole, 0.5 M 3 
NaCl. A linear gradient from 0.02 to 1 M imidazole was used to elute the recombinant protein. 4 
TrpD eluted at ~ 0.3 M imidazole. Fractions containing the eluted enzyme were assayed for 5 
activity, dialyzed overnight against PED buffer (50 mM potassium phosphate pH 7.5, 0.1 mM 6 
EDTA, 0.2 mM DTT) containing 20% glycerol and stored at –80°C. Proteins were purified to 7 
>95% purity, as judged by SDS-PAGE with the yield from a typical purification of 100 mg of 8 
purified protein per 4 liters of culture. 9 
Enzyme assays. Phosphoribosyltransferase activity was assayed fluorometrically (12, 13) by 10 
measuring the rate of disappearance of anthranilate at 25oC. The reaction mixture contained 15 11 
µM anthranilate, 0.3 mM 5-phosphoribose-1-pyrophosphate (PRPP), 10 mM MgCl2, 100 mM 12 
tricine buffer (pH 7.6), and 0.625 µg of purified enzyme (TrpD) in a final volume of 200 µl. 13 
Anthranilate was detected by fluorescence at 325nm excitation and 400nm emission 14 
wavelengths. 15 
Phosphoribosylamine-forming activity was determined using a modified assay initially described 16 
for PurF (17, 29). Synthesis of PRA from PRPP and ammonium was determined as a function of 17 
[1-14C]- glycinamide ribonucleotide (GAR) produced in a coupled reaction catalyzed by GAR 18 
synthetase (PurD) enzyme (Fig. 2B). A molecule of [1-14C]-glycine is condensed with PRA to 19 
yield GAR. The reactions were performed in 50 mM potassium phosphate buffer pH 8.0 in the 20 
presence of 10 mM PRPP, 10 mM MgCl2, 2.5 mM ATP, 25 mM 14C-glycine (26 nCi), 10 mM 21 
NH4Cl, 2 µg of GAR synthetase.  PurD was overexpressed and purified as previously described 22 
(27).  In a standard assay, reactions were started by the addition of 5-10 µg of purified TrpD and 23 
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9 
incubated at 37oC during 1 h. Various changes to this protocol are noted in the text as relevant 1 
for each experiment.  Labeled GAR and glycine were separated by thin layer chromatography on 2 
polyethyleneimine (PEI)-cellulose using a methanol:pyridine:water system (20:1:5) determined 3 
experimentally. The position of radioactive spots was detected using a Cyclone Storage 4 
Phosphor System (Packard Instrument Company), and their identity was confirmed with known 5 
standards. 6 
Protein quantification and manipulation. Protein concentration was calculated at 25oC using the 7 
equation A=ΣBC, where A equal A280-Ls, Ls equal A330 x 1.929, Σ is the molar extinction 8 
coefficient of the pure protein and C is protein concentration in moles/l. SDS-polyacrylamide gel 9 
electrophoresis (PAGE) was performed by the method of Laemmli (16) and protein bands were 10 
visualized after staining with 40:55:5:0.05 ethanol:water:acetic acid:Coomassie G-250 and 11 
destained in 40:55:5 ethanol:water:acetic acid. 12 
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10 
RESULTS 1 
TrpD- mediated PRA generation in vitro requires anthranilate. Previous genetic results 2 
suggested that purified TrpD would mediate PRA formation from PRPP and NH3. TrpD 3 
containing an N-terminal His-Tag fusion was purified to >95% purity and assayed for inherent 4 
phosphoribosyl transferase activity.  A typical preparation converted 1.9 µmoles of anthranilate 5 
to phosphoribosyl anthranilate per min when both anthranilate and PRPP were provided in the 6 
assay mix.  Potential formation of PRA was assessed utilizing PurD in a coupled assay, when 7 
PRPP, NH3 and TrpD were provided in the assay mixture. Under the conditions tested, PRA 8 
formation was detected only when anthranilate was also added to the reaction (Fig. 2).  When 9 
provided in place of anthranilate, methylanthranilate (a competitive inhibitor) failed to allow 10 
PRA formation (data not shown). This result suggested that the synthesis of PR-anthranilate was 11 
required for production of PRA detected in the presence of TrpD. 12 
PRA formation in the presence of anthranilate is non-enzymatic. Synthesis of PRA by TrpD was 13 
monitored as a function of anthranilate (0 - 150 µM) by the level of radio-labeled GAR ([1-14C]- 14 
glycinamide ribonucleotide) detected. Data in Fig. 3 showed that GAR produced was 15 
proportional to the concentration of anthranilate added up to 75 µM, where there was a plateau of 16 
product formation. The final concentration of GAR, as estimated from a linear curve generated 17 
with precursor glycine, was approximately twice the amount of anthranilate added. This result 18 
suggested that anthranilate (or a derivative) was allowing PRA synthesis but was not 19 
participating as a substrate in the reaction.  20 
The above result led to the hypothesis that PRA was synthesized non-enzymatically from 21 
a product of the TrpD reaction. Under the conditions used to assay phosphoribosyl transferase 22 
activity, TrpD quantitatively converted PRPP and anthranilate to PR-anthranilate after about five 23 
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11 
min (as measured by a loss in fluorescence at 400nm). Over the next 30 min, fluorescence 1 
increased, indicating a reappearance of anthranilate and corresponding to the breakdown of PR-2 
anthranilate (Fig. 4).     3 
The products of PR-anthranilate breakdown are anthranilate and R5P (30), suggesting 4 
that PRA might be generated by a non-enzymatic reaction between accumulating R5P and the 5 
ammonia present in the reaction mix. Non-enzymatic formation of PRA has been well 6 
characterized (23), and its potential contribution was determined by performing the coupled 7 
assay in two steps. PR-anthranilate was formed by TrpD from anthranilate and PRPP.  8 
Conversion of anthranilate to PR-anthranilate was judged to be complete when fluorescence in 9 
the mixture decreased to that of the blank. Proteins in the assay mix were then removed by ultra 10 
filtration with a 3 kDa cut off membrane, and the resulting eluant was provided as a source of 11 
R5P to a reaction mixture containing NH3 and the components for 14C-GAR synthesis. Data from 12 
this experiment, shown in Table 2, indicated that when PurD was the only enzyme in the assay 13 
mixture the eluant allowed GAR formation.  These data allowed the conclusion that non-14 
enzymatic PRA formation was occurring between R5P and NH3. Taken together the above 15 
results suggested that anthranilate was being recycled by TrpD to synthesize more PR-16 
anthranilate, which resulted in the continuous formation of R5P allowing non-enzymatic 17 
formation of PRA as depicted in Fig. 5.  18 
Metabolite accumulation can lead to PRA formation in vivo. A physiological role for non-19 
enzymatic formation of PRA has been discounted in the past.  During steady state metabolic 20 
conditions this conclusion is validated by the thiamine requirement of a purF mutant strain. PR-21 
anthranilate is the substrate for a bi-functional enzyme encoded by trpC. Strains lacking TrpC 22 
activity have been shown to accumulate anthranilate in the medium (30), which could suggest an 23 
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12 
accumulation of R5P endogenously.  A purF gnd trpC::Tn10 mutant strain was generated to 1 
determine if the process described in vitro could be forced to occur in vivo by manipulating 2 
metabolic flux. Two regulatory mutations were incorporated into the strain to ensure that 3 
metabolic flux reached the genetically blocked step in the presence of the required tryptophan.  4 
An insertion in trpR relieved repression (4, 25) and an allosterically insensitive variant of TrpE 5 
(trpE3613) prevented feedback inhibition (4, 5). The strain lacking trpC and defective in 6 
regulation by tryptophan showed significant growth in the absence of thiamine as shown in Fig. 7 
6.  This result was consistent with the hypothesis that the limiting metabolite for non-enzymatic 8 
PRA formation in vivo is R5P. 9 
 10 
Disruption of flux through the tryptophan biosynthetic pathway can increase PRA formation in 11 
vivo. The experiment above employed a contrived strain that was lacking a major biosynthetic 12 
enzyme and as such the value of this result in conclusions about a physiological role for non-13 
enzymatically generated PRA was limited.  Mutations that restored PurF-independent PRA 14 
synthesis, mapped to the tryptophan operon, and allowed retention of the ability to grow in the 15 
absence of tryptophan were sought using localized mutagenesis. A phage lysate grown on a DES 16 
mutagenized strain (DM1) was used to transduce strain DM6806 (purF2085 gnd-181 17 
trpC::Tn10d(Tc)) to Trp+ on medium containing adenine and thiamine. Trp+ transductants were 18 
replica-printed to minimal medium supplemented with adenine, and growth was scored. Seven 19 
Trp+ Thi+ mutants were isolated. Genetic reconstruction determined the causative mutation in 6 20 
of the 7 strains was 100% linked to the tryptophan operon, and these mutations were further 21 
characterized. 22 
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13 
Mutations in trpC allow PRA synthesis. The region between the trpH and trpC genes was PCR-1 
amplified and sequenced from each of the mutants. (The trpH gene is upstream and divergently 2 
transcribed with respect to the trp operon.) Six of the mutations allowing PRA synthesis were in 3 
trpC and one in trpE. Due to their prevalence, the trpC alleles were analyzed further. The 4 
causative lesion in each mutant strain is described in Table 3. All 6 mutations mapped to the 5 
phosphoribosylanthranilate isomerase (PR-AnI) domain of the bifunctional enzyme. The 6 
isomerase reaction is the first of the two sequential reactions catalyzed by TrpC. Two of the 7 
mutant enzymes (TrpCA405T and TrpCG435D) contained changes in conserved residues of the PR-8 
AnI active site, as determined by amino acid sequence alignments of the PR-AnI of ten different 9 
microorganisms (26). One mutation introduced an amber codon resulting in a TrpC enzyme with 10 
a predicted truncation of the PR-AnI domain (TrpCG339ter). The amino acid change in TrpCG255D 11 
affected a residue that serves as a bridge between the PR-AnI and the indole-3-glycerol-12 
phosphate synthase (IGPS) domains in E. coli and S. enterica TrpC (26). The location of these 13 
mutations in the three-dimensional structure the protein is illustrated in Fig. 7. 14 
Nutritional analyses of trpC mutants. Specific growth rates (µ) for the isolated mutant strains 15 
(DM7863-DM7870) and a control wild-type are shown in Table 4.  None of the trpC mutant 16 
strains displayed a significant requirement for tryptophan, indicating at least a low level of 17 
enzymatic activity remained in the mutant proteins.  Though unexpected for strain DM7869, low 18 
level read-through of nonsense codons could generate sufficient full length message for in vivo 19 
function (1). Each of the mutant strains grew in the absence of thiamine, while the strain 20 
containing a wild-type tryptophan operon (DM6418) did not. Significantly, addition of 21 
tryptophan (0.5mM) eliminated the growth of all mutant strains. The inhibition by tryptophan 22 
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14 
was reversed by the addition of thiamine and partially alleviated by the introduction of a 1 
feedback resistant allele of trpE (data not shown), as expected if flux regulation is involved. 2 
Together these results indicated that growth of these strains in the absence of thiamine was a 3 
result of PRA production by a tryptophan-regulated mechanism.  4 
trpC mutants excrete anthranilate. The phenotypic similarities between the strains carrying trpC 5 
point mutations and a strain lacking trpC, in addition to their location in the coding sequence, 6 
suggested these alleles had compromised the isomerase activity. Given the prototrophic nature of 7 
the relevant strains, the indirect aspect of available assays, and potential complexities of the 8 
metabolic network involved, the predicted accumulation of anthranilate was tested by bioassay.  9 
A strain containing trpE8, which creates an auxotropic requirement for anthranilate or 10 
tryptophan, was used as an indicator strain.  The tryptophan requirement of this strain is satisfied 11 
by 15 µM of anthranilate (data not shown).  A variety of relevant strains were grown in the 12 
appropriate medium and the presence of exogenous anthranilate was monitored by stabbing cells 13 
on a soft-agar overlay seeded with the trpE8 mutant strain. Results of a typical experiment are 14 
presented in Fig. 8. The figure shows that the parental strain (DM9784) fails to excrete a 15 
metabolite that allows growth of the trpE mutant.  In contrast, the trpC mutant strains excrete a 16 
compound that supplies the growth requirement of the trpE strain and is thus assumed to be 17 
anthranilate. 18 
 19 
 20 
DISCUSSION 21 
 All organisms maintain a complex set of biochemical interactions that make up the 22 
metabolic network. A key component of the metabolic network is the embedded robustness that 23 
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15 
allows an organism to compensate for defects in one metabolic branch by altering another. The 1 
studies described here were initiated to test the prediction that the AS-PRT (TrpDE) enzyme 2 
complex could generate phosphoribosyl amine (PRA) (27).  However, data from the in vitro 3 
studies unexpectedly led to the conclusion that PRA needed for thiamine synthesis could be 4 
generated non-enzymatically if carbon flux through the tryptophan biosynthetic pathway was 5 
altered. 6 
 The in vitro system described herein serendipitously allowed the generation (and 7 
detection) of PRA that was formed non-enzymatically from ribose-5-P and NH3.  Manipulation 8 
of the assay system allowed the conclusion that the TrpD enzyme mediated the conversion of 9 
PRPP to R5P through a PR-anthranilate intermediate (Fig. 6). Thus in this isolated system, the 10 
critical product of the TrpD reaction was R5P, generated by breakdown of the unstable PR-11 
anthranilate. The R5P then condensed with NH3 present to generate PRA. It is important to note 12 
that these results did not address the possibility that TrpD can enzymatically generate PRA under 13 
some condition(s). 14 
The instability of PR-Anthranilate has been previously described (7). However, a role for 15 
the breakdown products in metabolism had not been considered since the subsequent enzyme in 16 
the pathway (TrpC) would be expected to remove this metabolite before breakdown. The 17 
potential contribution of non-enzymatic formation of PRA to thiamine synthesis in vivo was 18 
explored genetically. Interruption of the trpC gene allowed thiamine independent growth in the 19 
absence of PurF.  However, while producing a positive result, this was a harsh test of this 20 
hypothesis since it restored one pathway (thiamine) at the expense of another (tryptophan). The 21 
isolation of mutations in trpC that did not compromise the ability of the cell to grow in the 22 
absence of tryptophan, but allowed growth without thiamine (in cells lacking purF) confirmed a 23 
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16 
physiological potential for non-enzymatic PRA formation. Cross-feeding studies detected the 1 
expected excretion of anthranilate, making all data consistent with accumulation of PR-2 
anthranilate being indirectly responsible for thiamine synthesis in these strains. These data allow 3 
the conclusion that R5P is the limiting metabolite for non-enzymatic formation of PRA in vivo, 4 
at least in the medium used. This conclusion explains why no mutations have been isolated that 5 
prevent PurF-independent thiamine synthesis when cells are grown on ribose.  Use of ribose as a 6 
sole carbon source would be expected to elevate R5P levels. 7 
Five of the trpC mutations restoring PRA synthesis affected residues in the PR-AnI 8 
domain and one mutation affected the single amino acid that serves as a bridge between the two 9 
domains. The diversity of mutations that resulted in a similar phenotype by distinctly altering the 10 
TrpC enzyme, yet failing to compromise tryptophan independent growth was unexpected.  The 11 
presence of one mutation that generated a termination codon was noteworthy since activity 12 
sufficient for tryptophan biosynthesis was maintained. It seems likely that low levels of read-13 
through of the UAG codon produced enough functional TrpC to allow synthesis of tryptophan. It 14 
was telling that each of the randomly generated mutations that survived the selection mapped to 15 
the isomerase domain of the protein.  This activity is the first of the two sequential reactions the 16 
enzyme catalyzes in tryptophan biosynthesis and significantly is the one that acts on PR-17 
anthranilate.  This result emphasized the need for the specific accumulation of PR-anthranilate. 18 
In a global context, this work illustrates several points.  First, the potential for non-19 
enzymatic synthesis of key metabolites is demonstrated. Strains were generated in which 20 
thiamine synthesis depended on the non-enzymatic formation of an intermediate. No significant 21 
growth defect resulted in these strains, indicating that all essential metabolic processes were 22 
functioning at a capacity that allowed growth on minimal medium. A second point of note was 23 
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the ease with which subtle changes in enzyme kinetics appeared to alter the metabolic network.  1 
This work suggests that even in highly conserved proteins, key residues involved in catalysis are 2 
not the only critical feature to be maintained. Finally, this work demonstrates that changes in a 3 
protein can alter metabolic flux in a way that has a global impact on metabolism, yet can not be 4 
predicted, or in fact measured if only one output is monitored.  As such, protein variants should 5 
be considered to be optimized for function in the native metabolic network. If this view is 6 
correct, it has implications for evaluating essential residues and protein evolution in the context 7 
of a single activity, or pathway.  Rather, analysis of the relevant network, and its conservation in 8 
different organisms may provide a better understanding of the forces at work to constrain and 9 
define metabolism and allow for the critical inherent robustness.  10 
 11 
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Table 1. Bacterial strains and plasmids. 1 
 2 
           3 
Strain     Genotype       4 
DM1          WT 5 
DM6806 purF2085 gnd181 trp::Tn10d(Tc) 6 
DM6418  purF2085 gnd-181 zdd-9147::Tn10d(Tc) 7 
DM8916 purF2085 gnd181 ∆trpEDCBA::Cm 8 
DM7863 purF2085 gnd181 trpC3620 9 
DM7864 purF2085 gnd181 trpC3625 10 
DM7865 purF2085 gnd181 trpC3621 11 
DM7867 purF2085 gnd181 trpC3622 12 
DM7868 purF2085 gnd181 trpC3623 13 
DM7869 purF2085 gnd181 trpC3624 14 
DM7870 purF2085 gnd181 trpC3626 15 
DM9719 purF2085 gnd181 trpE3613 ∆trpR::Cm trpC::Tn10d(Tc) 16 
DM9784 purF2085 gnd181 17 
DM9891 purF2085 gnd181 zdd1947::Tn10d(Tc) trpC3620 18 
TrpE8  trpE8 19 
 20 
         21 
Plasmids   Source   Insert  22 
pET-28a (kanr)  Novagen  None 23 
pET-trpD (kanr)  This work  trpD 24 
 25 
 26 
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 1 
 Table 2.  Non-enzymatic formation of PRA. 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
Assay conditions were as described in the text with 5 initial reactions containing the 10 
indicated additions. Following incubation, protein was removed to generate the eluant of the 11 
corresponding number.  The eluants were added to the reaction mixture containing NH3, ATP, 12 
PurD and 14C-glycine, and GAR formed was monitored by phosphorimage analyses. 13 
 
anumbers represent phosphorimager units representing the amount of GAR formed.14 
Step #1              Reaction # 
     Additions   1   2  3  4   5 
   Anthranilate   +   +  +   -   + 
           PRPP   +   +  -  +   + 
           ATP   -   -  -   -   + 
           TrpD    -   +  +  +   + 
Step#2    Eluant from reaction # 
 1  2 3  4   5 
14GAR formeda 74 374 59 65 290 
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Table 3. Mutations and amino acid changes that allow PurF-independent PRA synthesis. 1 
Strain trp allele 
Causative 
mutation 
Amino acid 
change 
 
3-dimensional location a 
DM7863 trpC3620 G-A A405T 
     Conserved active site residue 
      in PR-AnI domainb 
DM7865 trpC3621 G-A G255D 
      Hinge region between 
      PR-AnI and IGPS 
DM7867 trpC3622 G-A A358T 
      Non conserved residue 
      in PR-AnI domain 
DM7868 trpC3623 G-A G435D 
Fully conserved active site 
residue in PR-AnI domain 
DM7869 trpC3624 C-T 
G339Ter 
(UAG) 
     Truncates half of the 
     PR-AnI domain 
DM7870 trpC3626 
Insertion at 
bp 798 
   6 a acid  
   insertion 
     Beginning of the first  
     α-helix of  PR-AnI domain  
 2 
a 2.8-A resolution crystal structure of TrpC from Escherichia coli as solved by Priestle et al. (26). 3 
bConserved residues were determined by the amino acid sequence alignment of TrpC from 4 
several organisms (26). 5 
 6 
 7 
 8 
 9 
 10 
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Table 4. Mutations in the tryptophan operon restore thiamine-independent growth.  1 
 Specific growth rate (µ) in minimal glucose medium  
supplemented witha: 
 
 
Strain trp allele Ade Ade Trp Ade Thi Ade Trp Thi 
DM6418 WT 0.087 0.072 0.459 0.439 
DM7863 trpC3620  0.365 0.030 0.393 0.415 
DM7865 trpC3621 0.290 0.074 0.323 0.410 
DM7867 trpC3622 0.262 0.047 0.378 0.400 
DM7868 trpC3623  0.324 0.080 0.390 0.409 
DM7869 trpC3624  0.315 0.086 0.379 0.381 
DM7870 trpC3626 0.295 0.032 0.319 0.396 
 2 
 
aStrains were grown in minimal glucose medium with the indicated supplements at 37oC as 3 
described in Materials and Methods. Ade, adenine; Trp, tryptophan; Thi, thiamine. The specific 4 
growth rate (µ) was determined by the equation ln(X/X0)/T, where  X is A650, X0 is A650 at time 5 
zero, and T is time in hours. 6 
WT, wild-type. 7 
 8 
 9 
 10 
 11 
 12 
 13 
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FIGURE LEGENDS 1 
Fig 1. Reactions catalyzed by the TrpE, TrpD and TrpC enzymes in the tryptophan 2 
biosynthetic pathway. A) The heterotetrameric complex (TrpE2D2) catalyzes glutamine-3 
dependent anthranilate synthesis. The second activity, PR-anthranilate synthesis, is performed by 4 
the phosphoribosyl transferase subunit (TrpD). Gln, glutamine; Glu, glutamate; Pyr, pyruvate; 5 
PRPP, 5-phosphoribosyl 1-pyrophosphate. B) Reactions catalyzed by the bi-functional enzyme 6 
TrpC. The carboxy-terminal domain catalyzes the isomerization of N-(5’-phosphoribosyl) 7 
anthranilate to CdRP. The amino-terminal domain catalyzes the decarboxylation of CdRP to 8 
indole-3-glycerol-phosphate. PR-Ant, N-(5’-phosphoribosyl) anthranilate; CdRP, 1-(o-9 
carboxyphenylamino)-1’-deoxyribulose-5’-phosphate; InGP, indole-3-glycerol-phosphate 10 
 11 
FIG. 2. 14C-GAR formation in the presence of TrpD enzyme requires anthranilate. (A) 12 
Reactions were performed in 50 mM potassium phosphate buffer pH 8.0 in the presence of 150 13 
µM anthranilate (when added), 10 mM PRPP, 10 mM NH3, 6 mM Mg(Ac)2, 2.5 mM ATP, 25 14 
mM 14C-glycine (26 nCi) and 2 µg of GAR synthetase. Reactions were started by the addition of 15 
5 µg of TrpD enzyme and incubated at 37ºC for 1 h. Labeled GAR and glycine were separated 16 
on PEI-cellulose using a methanol/pyridine/water (20:1:5) solvent system. (+) addition; (-) no 17 
addition and visualized using a Cyclone Storage Phosphor System. (B) A schematic of the 18 
coupled assay used to detect PRA formation is shown. 19 
 20 
FIG. 3. GAR synthesis vs. anthranilate concentration. Production of GAR by wild-type TrpD 21 
was determined in the presence of increasing concentrations of anthranilate. The assay was 22 
performed as described in Materials and Methods in the presence of 10 mM PRPP and 10 mM 23 
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NH3. Reactions were started by the addition of 5 µg of the TrpD enzyme and incubated at 37°C 1 
for 1 h. The data represents the average of duplicate experiments and detected 14C-GAR was  2 
quantified in PhosphorImager (PI) units. 3 
 4 
FIG 4 . Degradation of N-(5’-phosphorybosyl)-anthranilate (PR-Ant). The phosphorybosyl 5 
transferase activity of TrpD was assayed as described in Materials and Methods in the presence 6 
of 1mM PRPP, 1mM anthranilate and 0.3 µg of TrpD enzyme. Disappearance of anthranilate 7 
was followed fluorometrically (excitation wavelenght: 325nm; emission: 400nm) in the presence 8 
(Ο), or absence () of TrpD. 9 
 10 
FIG. 5. Non-enzymatic PRA synthesis from NH3 and R5P in the presence of TrpD. R5P 11 
released from the degradation of PR-anthranilate formed by TrpD reacts non-enzymatically with 12 
NH3 to produce PRA. PRPP, phosphoribosyl pyrophosphate; Ant., anthranilate; PR-Ant., 13 
phosphoribosyl-anthranilate; R5P, ribose 5-phosphate; PRA, phosphoribosyl amine 14 
 15 
FIG. 6. Metabolite accumulation allows PRA formation in vivo. Strains were grown in 16 
minimal medium supplemented with adenine and tryptophan. DM9784 (purF2085 gnd181) (), 17 
DM9719 (purF2085 gnd181 ∆trpR3614 trpE3613 trpC::Tn10) (●). Addition of thiamine 18 
restores growth of DM9784 ().  Data shown are an average of 2 independent cultures with error 19 
bars indicated. 20 
 21 
FIG. 7. 3-dimensional localization of mutations restoring PRA synthesis. Structure of PR-22 
AnI-IGPS (TrpC) (26). Residue changes are indicated in different colors. The region presumed 23 
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to be predominately truncated in TrpCG339Ter is shown in yellow starting with residue G339 in 1 
pink. The location of the active sites of the PR-AnI and IGPS is indicated by I and S, 2 
respectively. Structural depictions were generated using PyMol software version 0.99 3 
(http://pymol.sourceforge.net/) 4 
 5 
FIG. 8. Anthranilate excretion by trpC mutants. Feeding experiments were performed as 6 
described in Materials and Methods. The indicator strain trpE8 was seeded as an overlay on 7 
minimal medium plates supplemented with adenine and thiamine. Indicated mutant strains were 8 
stabbed into the agar lawn from overnight cultures.  Mutant strains used were: DM7870 9 
(purF2085 gnd181 trpC3626), 7863 (purF2085 gnd181 trpC3620), 7865 (purF2085 gnd181 10 
trpC3621), 7869 (purF2085 gnd181 trpC3624) and 7868 (purF2085 gnd181 trpC3623). Strain 11 
DM9784  (purF2085 gnd181) is the parental control and the only growth seen is of the strain 12 
itself. Plates were incubated at 37°C for 24 hours.  13 
 14 
 15 
 16 
 17 
 18 
 19 
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